Selectivity of the NF-{kappa}B response.
NF-kappaB is activated by many stimuli and NF-kappaB binding sites have been identified in a wide variety of genes. Yet, NF-kappaB-dependent gene expression must be stimulus- and cell-type-specific. In others words, the cellular response to different NF-kappaB activating stimuli, such as TNFalpha, IL-1, and LPS, must be different; and the response of different cell types, such as lymphocytes, fibroblasts, or epithelial cells, to the same NF-kappaB-inducing stimulus must also be different. Finally, kinetics of gene expression must be accounted for, so that all NF-kappaB-dependent genes are not activated simultaneously even if cell type and stimulus are constant. Here, we explore the mechanistic framework in which such regulatory aspects of NF-kappaB-dependent gene expression have been analyzed because they are likely to form the basis for physiological responses.
Sen
Ranjan
R
Laboratory of Cellular and Molecular Biology, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21225, USA. ranjan.sen@nih.gov <ranjan.sen@nih.gov>
Smale
Stephen T
ST
D000818:Animals; D020672:I-kappa B Proteins / Q000502:physiology; D007375:Interleukin-1 / Q000502:physiology; D051379:Mice; D016328:NF-kappa B / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D020672:I-kappa B Proteins; D007375:Interleukin-1; D016328:NF-kappa B; D014409:Tumor Necrosis Factor-alpha
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000224
20066094
Mol Cell. 1998 Apr;1(5):661-71
9660950
Immunity. 1996 Nov;5(5):479-89
8934574
Oncogene. 2006 Oct 30;25(51):6781-99
17072328
J Immunol. 1996 Aug 1;157(3):1149-55
8757620
Annu Rev Immunol. 1998;16:225-60
9597130
J Exp Med. 2004 Jul 5;200(1):107-13
15226358
Mol Cell Biol. 2001 Jul;21(14):4837-46
11416157
Immunity. 2004 Jul;21(1):19-30
15345217
Oncogene. 2006 Oct 30;25(51):6706-16
17072323
Genes Dev. 2009 Apr 1;23(7):849-61
19339690
J Immunol. 2007 Jun 1;178(11):6777-88
17513725
Mol Cell. 2002 Mar;9(3):625-36
11931769
Immunity. 2005 Oct;23(4):445-58
16226509
EMBO J. 2009 Apr 22;28(8):1055-66
19262565
Nat Rev Immunol. 2008 Nov;8(11):837-48
18927578
EMBO J. 2002 Dec 2;21(23):6539-48
12456660
Genes Dev. 2006 Feb 1;20(3):282-96
16452502
Mol Cell Biol. 2006 Mar;26(6):2399-407
16508014
Genes Dev. 2008 May 1;22(9):1159-73
18408078
Cell. 2004 Aug 20;118(4):453-64
15315758
Nat Immunol. 2002 Jan;3(1):69-75
11743587
Mol Cell Biol. 1996 Oct;16(10):5444-9
8816457
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12705-10
11058167
Nat Immunol. 2009 Feb;10(2):158-66
19122654
Annu Rev Immunol. 2009;27:693-733
19302050
Science. 2001 Aug 31;293(5535):1653-7
11533489
Nat Immunol. 2009 Mar;10(3):281-8
19198593
Mol Cell Biol. 1992 Oct;12(10):4412-21
1406630
Science. 2005 Sep 16;309(5742):1857-61
16166517
J Biol Chem. 2003 Jan 24;278(4):2758-66
12419806
Genes Dev. 1997 Dec 15;11(24):3482-96
9407039
Cell. 1986 Dec 26;47(6):921-8
3096580
EMBO J. 2007 Jan 24;26(2):436-47
17183367
J Virol. 2002 May;76(10):4928-39
11967310
Oncogene. 1999 Nov 22;18(49):6845-52
10602460
Mol Cell Biol. 2001 Jul;21(14):4737-47
11416149
J Immunol. 2007 Jan 1;178(1):186-91
17182554
J Biol Chem. 2001 Mar 16;276(11):7701-4
11152669
Mol Cell Biol. 1999 Oct;19(10):7088-95
10490645
Genes Dev. 2004 Sep 15;18(18):2195-224
15371334
J Immunol. 2003 Apr 1;170(7):3724-31
12646638
J Cell Biol. 2006 Jun 5;173(5):659-64
16735576
Cell. 1990 Apr 20;61(2):255-65
2184941
EMBO J. 2006 Jan 11;25(1):139-49
16319923
Mol Cell Biol. 1997 Jul;17(7):4051-8
9199340
Nat Immunol. 2007 Jun;8(6):584-91
17468759
Immunity. 1999 Mar;10(3):387-98
10204494
J Immunol. 2007 Jun 1;178(11):7097-109
17513759
EMBO J. 1999 Dec 1;18(23):6682-93
10581242
Immunogenetics. 1999 May;49(5):395-403
10199915
Oncogene. 1999 Nov 22;18(49):6888-95
10602464
Cell. 2009 Jul 10;138(1):114-28
19596239
Nat Immunol. 2005 May;6(5):439-45
15843800
Genes Dev. 2005 Sep 15;19(18):2138-51
16166378
Mol Cell Biol. 2000 Mar;20(6):2269-84
10688673
Nature. 2005 Apr 28;434(7037):1138-43
15858576